To assess the impact of collagen peptides versus free amino acids on myofibrillar and connective tissue protein synthesis rates in muscle and skin obtained during recovery from exercise and rest in vivo in humans.
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
Muscle and connective tissue research (no disorders)
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
To assess the impact of collagen peptides versus free amino acid ingestion
after exercise on myofibrillar and connective tissue protein synthesis rates in
muscle tissue obtained during recovery from exercise in vivo in humans.
Secondary outcome
- To assess the impact of collagen peptides versus free amino acid ingestion on
connective tissue protein synthesis rates in skin.
- To characterize plasma amino acid availability following ingestion of
collagen protein versus free amino acids.
Background summary
Dietary protein ingestion stimulates muscle protein synthesis rates and further
augments the muscle protein synthetic response to a single bout of exercise.
The anabolic properties of dietary protein ingestion appear to be largely
attributed to the post-prandial rise in circulating plasma essential amino acid
concentrations, with leucine being of particular interest. In support, protein
supplementation during recovery from exercise has been shown to augment the
gains in muscle mass and strength following more prolonged exercise training .
Stable isotope methodology is generally applied to assess the impact of protein
ingestion on muscle protein synthesis rates in vivo in humans. Incorporation
rates of stable isotope labeled amino acids in muscle tissue are assessed
following primed continuous labeled amino acid infusions at rest or during
recovery from exercise. The focus is generally directed towards the
post-prandial increase in the synthesis rates of contractile muscle protein,
referred to as myofibrillar protein. As a consequence, there is little
information on the impact of nutrition and exercise on the synthesis rates of
connective tissue protein in skeletal muscle. The collagenous extracellular
matrix of muscle tissue has recently regained much interest for its key role in
transferring the forces generated by the contractile filaments throughout the
muscle and onto the ligaments, tendons, and bone. This connective tissue matrix
has been shown to express a high level of plasticity and collagen protein
synthesis rates have been shown to rapidly increase in muscle tissue following
exercise. However, the impact of protein ingestion with or without prior
exercise on connective tissue protein synthesis rates in muscle remains to be
established.
Dairy protein is often considered the preferred protein source to maximize
myofibrillar protein synthesis rates. However, dairy protein contains
relatively little glycine and proline and may, therefore, be ineffective to
support an increase in connective tissue protein synthesis rates at rest or
during recovery from exercise. Recently, we demonstrated that milk protein
ingestion actually lowers plasma glycine availability, implying that connective
tissue remodeling during recovery from exercise may be compromised by low
plasma glycine availability. A promising alternative are collagen peptides,
which are rich in glycine and proline and have, therefore, been proposed as the
preferred protein source to support connective tissue remodeling. While the
impact of collagen peptide ingestion on connective tissue protein synthesis
rates in skeletal muscle and skin tissue remains to be established, recent
studies have reported that collagen peptide supplementation can further augment
skeletal muscle mass and strength gains following prolonged exercise training.
Furthermore, it has been suggested that collagen peptides have anabolic
properties that extend beyond the provision of their corresponding amino acid
precursors. Whether collagen peptides contain specific bioactive peptides that
can further stimulate myofibrillar and/or connective tissue protein synthesis
rates in muscle and skin has never been addressed in vivo in humans.
Study objective
To assess the impact of collagen peptides versus free amino acids on
myofibrillar and connective tissue protein synthesis rates in muscle and skin
obtained during recovery from exercise and rest in vivo in humans.
Study design
Double-blind, parallel-group, placebo-controlled intervention study
Intervention
Participants will perform unilateral resistance exercise followed by the
ingestion of either 30 g of collagen peptides, 30 g free amino acids (matching
the profile of collagen peptides), or a non-caloric placebo (flavored water).
Continuous intravenous tracer infusion will be applied, and plasma, muscle and
skin samples will be collected in order to assess the muscle and skin protein
synthetic response.
Study burden and risks
The burden and risks involved in participating in this experiment are small.
Insertion of the catheters in a vein is comparable to a normal blood draw and
the only risk is a small local hematoma. Muscle and skin biopsies will be
obtained under local anesthesia by an experienced physician. The muscle biopsy
may cause some minor discomfort, which is comparable to muscle soreness or the
pain one has after bumping into the corner of a table. The area of the skin
biopsy might feel a bit uncomforable the next days, but will only result in
minor discomfort. During the experimental trial 17 blood samples (~170mL total)
will be obtained. The total amount of blood collected is less than half the
amount of a blood donation and will be completely restored in approximately 1
month. The stable isotope amino acids tracers that will be infused
intravenously during the experimental trial are produced according to GMP
standards and are safe for human use. Participants will be instructed on proper
utilization of the exercise equipment by the researcher to prevent injury.
Participants will visit the University two times. The first visit will involve
a screening visit (3 h), during which the eligibility of the participant will
be assessed and a DEXA scan will be performed. Additionally, participants will
be familiarized with single leg exercise on the leg press and leg extension
machine. The single leg one repetition maximum (1RM) will be determined on the
same machines. For the second visit (experimental trial) participants are
required to come to the University in a fasted state, not having consumed any
food or beverages (except for water) as from 22:00 the evening before. Also, 2
days prior to the experimental trial participants need to record their food
intake and activities performed. During these 2 days participants are not
allowed to perform heavy physical exercise or drink alcohol. Filling out the
food and activity log properly will take the participant 30-45 min each day.
There is no direct benefit for the participants, except from their contribution
to scientific knowledge.
Universiteitsingel 50
Maastricht 6229 ER
NL
Universiteitsingel 50
Maastricht 6229 ER
NL
Listed location countries
Age
Inclusion criteria
- Males and females
- Aged between 18-35 years
- Healthy, recreationally active (participating in recreational sports
activities * 3 times per week)
- BMI 18.5 - 30 kg/m2
- No physical limitations (i.e. able to perform all activities associated with
daily living in an independent manner).
Exclusion criteria
- Pregnant
- Third generation oral contraceptives
- Hormone replacement therapy
- Smoking
- Musculoskeletal disorders
- Use of any medications known to affect protein metabolism (i.e.
corticosteroids, non-steroidal anti-inflammatories, or prescribed acne
medications).
- Participation in any structured regular exercise program
- Chronic use of gastric acid suppressing medication or anti-coagulants
- Unstable weight over the last three months
- Pathologies of the gastrointestinal tract
- Blood donation in the past 2 months
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL76260.068.20 |